Canopy Growth Corporation - Common Shares (CGC)

Curaleaf is attempting to acquire Canopy Growth's rival, Aurora Cannabis, and there could be more consolidation to come in the industry.

Canopy Growth (NASDAQ:CGC) is positioning itself for further expansion in medical cannabis, European markets and Canadian recreational cannabis after restructuring operations, reducing costs and acquiring MTL Cannabis, President and CEO Luc Mongeau said during a Canaccord Genuity presentation. Mong

The turnaround is becoming more believable.

Canopy Growth is a marijuana stock, but U.S. regulations aren't the main driver of its business.

Canopy Growth (NASDAQ:CGC) reported first-quarter fiscal 2027 net revenue of C$81.2 million, up 13% from the prior-year period, as the company recorded year-over-year growth across its cannabis and Storz & Bickel businesses. Chief Executive Officer Luc Mongeau said the quarter marked the first

The next key catalyst for this cannabis stock lies in the hands of a U.S. Federal Government agency.

The president directed federal authorities to reschedule medical marijuana.

A lower stock price doesn't eliminate investment risk.

Shares of the cannabis company have fallen below the $1 mark again.

Be careful before bucking the bearish trend.

Canopy Growth's medical marijuana division had a great quarter, but the rest of the business wasn't so lucky.

Canopy Growth is a much riskier stock than it was five years ago.

Canopy Growth (NASDAQ:CGC) reported higher fiscal fourth-quarter revenue and said it entered fiscal 2027 with a stronger balance sheet following a year of restructuring, cost cuts and the acquisition of MTL Cannabis. On the company’s earnings call, Chief Executive Officer Luc Mongeau described fisc

It will likely be more of the same from here on out for this cannabis player.

Several key metrics point to improving fundamentals.

The move only shifted a certain category of weed.

When a company restates its earnings, it often indicates mistakes were made, which can be a troubling issue for a penny stock.

It's unfitting that the marijuana seller has "growth" in its name.

The cannabis company has reduced debt and stacked up cash, but profitability remains elusive.

After years of heavy losses and repeated restructurings, Canopy Growth is showing early signs of stabilization.

The pot stock is up over 30% in just the past month.

Canopy Growth shares are up 25% over the past month, but investors need to keep in mind where it started.

Canopy Growth Corp (NASDAQ:CGC) shares are falling Thursday, pulling back after Wednesday's rally on U.S. cannabis policy shift.

Shares of Canopy Growth (NASDAQ: CGC) are surging Wednesday afternoon following news of a potential major shift in federal cannabis policy.

Err on the side of caution with this falling knife.